Drug Trial Radar · NCT05721235
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
Last checked: Nov 20, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
123
Actual
Start
Jun 2, 2023
Primary completion
Jul 31, 2025
Study completion Jul 31, 2025
Sponsor
- Lead sponsor
- Corium, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Premier Research; Prometrika, LLC; Almac; Worldwide Clinical Trials
- First posted
- Feb 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The is a multicenter, dose-optimized, open-label, safety/ tolerability and pharmacokinetic (PK) study with Azstarys® in children 4 and 5 years of age with attention-deficit/hyperactivity disorder (ADHD). The primary objective is to determine the safety and tolerability of treating children 4 and 5 years-of-age with ADHD with Azstarys® for up 12 months. Approximately 100 subjects will be enrolled. Approximately 20 sites will participate.
Conditions
- Attention Deficit/Hyperactivity Disorder
Interventions
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)Drug
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in Sleep BehaviorTime frame: 12 Months
- Percent Change in Body WeightTime frame: 12 months
- Percentile Change in Body HeightTime frame: 12 Months
- Percentile Change in Body WeightTime frame: 12 months
- Percent Change in Body HeightTime frame: 12 Months
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners (PRP)
Little Rock, Arkansas
Advanced Research Center (ARC)
Anaheim, California
IMMUNOe International Research Center
Centennial, Colorado
Clinical Neuroscience Solutions - Orlando
Jacksonville, Florida
Accel Research Sites - Lakeland
Lakeland, Florida
Accel Research Sites - Maitland
Maitland, Florida
South Florida Research Phase I-IV INC
Miami Springs, Florida
CNS Healthcare - Orlando
Orlando, Florida
iResearch Atlanta
Decatur, Georgia
CenExel iResearch, LLC
Savannah, Georgia
Sky Clinical Research Network Group P.C.
Union City, Georgia
DelRicht Research - Touro Medical Center
New Orleans, Louisiana
St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri
Boeson Research
Missoula, Montana
Alivation Research, LLC
Lincoln, Nebraska
Center For Psychiatry and Behavioral Medicine Inc
Las Vegas, Nevada
Clinical Neuroscience Solution, Inc
Memphis, Tennessee
Houston Clinical Trials
Bellaire, Texas
AIM Trials
Plano, Texas
Flourish Research
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.